Transcode Therapeutics

Developer of mRNA therapeutics to treat cancer

placeBoston, Massachusetts, United States calendar_todayFounded 2015 groups19 employees language transcodetherapeutics.com

Registered entities

Social engagement

Social engagement: 2.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Private equity125%
Other / undisclosed250%

Recent activity

18 Jun 2026
Event
Virtual webcast overview of Phase 2a trial of TTX-MC138
17 Jun 2026
Event
webcast
16 Jun 2026
Event
webcast
Coming soon